Marshall Wace’s Arrowhead Research ARWR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.9M Buy
305,031
+125,458
+70% +$9.27M 0.02% 630
2026
Q1
$11.3M Buy
179,573
+55,718
+45% +$3.53M 0.01% 918
2025
Q4
$8.22M Sell
123,855
-1,312,985
-91% -$64.4M 0.01% 943
2025
Q3
$49.6M Sell
1,436,840
-719,158
-33% -$15.8M 0.05% 321
2025
Q2
$34.1M Buy
2,155,998
+2,096,238
+3,508% +$30.1M 0.04% 403
2025
Q1
$761K Sell
59,760
-26,873
-31% -$489K ﹤0.01% 1897
2024
Q4
$1.63M Buy
+86,633
New +$1.78M ﹤0.01% 1526
2023
Q4
Sell
-107,648
Closed -$2.89M 2158
2023
Q3
$2.89M Sell
107,648
-193,393
-64% -$5.92M 0.01% 1067
2023
Q2
$10.7M Buy
+301,041
New +$10.4M 0.02% 702
2022
Q2
Sell
-182,799
Closed -$8.41M 3397
2022
Q1
$8.41M Buy
+182,799
New +$9.05M 0.02% 1001
2021
Q3
Sell
-250,380
Closed -$20.7M 3002
2021
Q2
$20.7M Buy
+250,380
New +$18.6M 0.09% 227
2021
Q1
Sell
-287,817
Closed -$22.1M 2453
2020
Q4
$22.1M Buy
+287,817
New +$18.4M 0.12% 172

Other funds holding ARWR

Marshall Wace's ARWR Position: Q2 2026 in Review

Marshall Wace increased its Arrowhead Research (ARWR) stake by 70% in Q2 2026, buying an estimated $9.27M and bringing the position to 305,031 shares worth $24.9M. The position accounts for 0.02% of the portfolio, ranked #630.

Marshall Wace first reported a position in ARWR in Q4 2020 and has held it in 12 quarters since. The position peaked at $49.6M in Q3 2025. 500 funds tracked by Wall St. Rank hold ARWR as of Q2 2026.

  • Marshall Wace held 305,031 shares of Arrowhead Research worth $24.9M as of Q2 2026.
  • Marshall Wace bought 125,458 Arrowhead Research shares in Q2 2026, an estimated $9.27M.
  • Arrowhead Research made up 0.02% of Marshall Wace's portfolio in Q2 2026, its #630 holding.
  • Marshall Wace first reported a position in Arrowhead Research in Q4 2020 and has held it in 12 quarters since.
  • Marshall Wace's Arrowhead Research position peaked at $49.6M in Q3 2025.
  • 500 funds tracked by Wall St. Rank held Arrowhead Research as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.